"Designing Growth Strategies is in our DNA"

Middle East & Africa Dry Eye Syndrome Market Size, Share & COVID-19 Impact Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2023-2030

Region : Middle East | Format: PDF | Report ID: FBI107539

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The Middle East & Africa is the fourth largest region in the global dry eye syndrome market. It is projected to grow at a CAGR of 5.2% during the forecast period. The global market for dry eye syndrome is projected to grow from USD 6.61 billion in 2022 to USD 11.26 billion by 2030.


Growing demand for eye care products for the treatment of this condition has led market players in the region to expand their production capacity by making strategic alliances with native players. For example, in July 2020, Ntc s.r.l. granted an exclusive license and distribution rights to Taro Pharmaceuticals in Israel for its fixed combination of an ophthalmic quinolone antibiotic with an anti-inflammatory steroid in eye drops. Similar efforts from leading players for the development of innovative prescription drugs will accelerate the Middle East & Africa dry eye syndrome market size during the forecast duration.


Based on country/sub-region, our report on the Middle East & Africa dry eye syndrome market covers the following countries/regions – GCC, South Africa, and the Rest of the Middle East & Africa.


LATEST TRENDS


Incorporation of Nanomedicine in Treatment May Pose Growth Potential


One of the key trends observed in the market is the rising application of nanoparticles in ocular diseases that allows targeted delivery, slow-release, and enhanced pharmacokinetics, therefore improving the bioavailability of drugs in the eyes. Nanomedicine offers ultra-small size particles, having versatility and target specificity, and has recently been widely investigated for treating this condition. Drugs formulated as nanoparticles can enhance the treatment of this condition with long-term drug release capacity and will reduce dosing frequency compared to topical treatments. The incorporation of such technologies for therapeutics in this market is expected to offer improved patient outcomes, leading to more robust patient adoption. Hence, such ongoing research and a growing pipeline for dry eye products are predicted to be a new trend for the future.


DRIVING FACTORS


Rising Prevalence of this Condition May Propel the Market Growth


One of the positive market-impacting factors for this region’s growth is the growing prevalence of this condition, which may lead to an increase in its diagnosis rate. This is expected to drive the demand for its treatment across the region. Companies engaged in the market are focusing on making strategic initiatives to expand their product presence in this region to meet the existing demand. They are also focusing on upscaling their production capacity through the expansion of its manufacturing facility.



  • As per an article published by SA Ophthalmology Journal in January 2023, the prevalence of dry eye syndrome in South Africa is 54.9%. Such high prevalence in the key countries of this region for this condition is anticipated to offer growth opportunities for market players to introduce novel eye care products in the coming years leading to the market growth. This is also expected to boost the adoption of a wide range of drugs, including OTC drugs.


RESTRAINING FACTORS


Request a Free sample to learn more about this report.


Limited Awareness Regarding the Condition to Limit the Market Growth 


Despite the growing prevalence of this condition, one of the key factors limiting the market growth is the lack of awareness regarding the treatment options available across the region. Limiting factors in the Middle East include poor patient education concerning this condition, lack of proper general practitioner system, irregular follow-up, high rates of refractive eye surgery, high rates of contact lens wear, and environmental factors. The confluence of such factors severely limits the market growth potential. Moreover, many studies witnessed poor attitudes of the general population toward treatment related to this disease as most of them do not visit routinely to an ophthalmologist. Furthermore, the high cost of specialty dry eye products may also limit the Middle East & Africa dry eye syndrome market growth.



  • As per a study published by the International Journal of Medicine in Developing Countries in January 2021, a study was conducted amongst the populace in Saudi Arabia in which 88.9% of the respondent indicated that they did not have a routine ophthalmologist visit. Such instances demonstrate that the diagnosis rate is low in this region, which may lead to a lower adoption rate of these eye care products, limiting the Saudi Arabia market potential.


KEY INDUSTRY PLAYERS


In the Middle East & Africa, the competitive landscape has the presence of some of the prominent players such as AbbVie, Inc., Alcon, and Novartis AG. These companies are focused on strengthening their supply and demand by upscaling their production capacity.


Some other market players include Bausch & Lomb Pvt Ltd. and Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Johnson & Johnson Vision Care, Inc., and others. These companies are focused on expanding their Middle East & Africa dry eye syndrome market share by making a strategic alliance with native players to strengthen their distribution network across the regions.


LIST OF KEY COMPANIES PROFILED:



KEY INDUSTRY DEVELOPMENTS:



  • September 2022: Johnson & Johnson Vision Care, Inc. invested USD 118 million to expand its Ireland facility.

  • September 2021: Ntc s.r.l. entered into a partnership with STADA Arzneimittel AG to commercialize its ophthalmic products in the Middle East and North Africa (MENA) that are intended to address several ophthalmic diseases, blepharitis, dry eye, and allergy.

  • October 2020: Santen Pharmaceutical Co., Ltd. announced a partnership with Orbis International to address the increasing burden of eye diseases in low and middle-income countries, especially in Asia.


REPORT COVERAGE


To gain extensive insights into the market, Request for Customization


The Middle East & Africa dry eye syndrome market research report provides qualitative and quantitative insights on the market and a detailed analysis of the Middle East & Africa market size & growth rate for all possible segments in the market. Along with the market overview, the report provides an elaborative impact analysis of drivers and restraints along with competitive landscape. Various key insights presented in the report are prevalence of the condition, by key countries, new product launches, reimbursement policies, regulatory scenario, healthcare industry overview, key countries, and the impact of COVID-19 on the market.


Report Scope & Segmentations






















































  ATTRIBUTE



  DETAILS



Study Period



2019-2030



Base Year



2022



Estimated Year



2023



Forecast Period



2023-2030



Historical Period



2019-2021



Growth Rate



CAGR of 5.2% from 2023 to 2030



Unit



Value (USD billion)



Segmentation



By Product, Distribution Channel, and Country/Sub-Region



By Product




  • Anti-inflammatory Products

    • Cyclosporin

    • Corticosteroids

    • Others



  • Artificial Tears and Lubricants

  • Others



By Distribution Channel




  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

  • Others



By Country/Sub-Region




  • GCC

  • South Africa

  • Rest of Middle East & Africa



Frequently Asked Questions

Growing at a CAGR of 5.2%, the market will exhibit steady growth in the forecast period (2023-2030).

The rising incidence of dry eye disease across the region and increasing strategic initiatives made by market players to expand product presence are some of the major factors driving the growth of the market.

AbbVie, Inc., Alcon, Novartis AG, and Santen Pharmaceutical Co., Ltd. are the major market players in the Middle East & Africa market.

GCC dominated the market in 2022.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • May, 2023
  • 2022
  • 2019-2021
  • 109

    CHOOSE LICENSE TYPE

  • $3850
    $4850
    $5850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X